Omar Nadeem, MD, a physician at Dana-Farber Cancer Institute and an instructor in medicine at Harvard Medical School, discusses individualizing therapy for patients with multiple myeloma. As more therapies become available, more thought will have to be put into determining how best to sequence agents. In the relapsed setting, that will be the most important...Continue Reading